Evidence map›Paper›PMID 31220342›Full record

ArticleImmunology2019

Adipocytokines leptin and adiponectin function as mast cell activity modulators.

Paulina Żelechowska, Ewa Brzezińska-Błaszczyk, Magdalena Wiktorska, Sylwia Różalska, Sebastian Wawrocki, Elżbieta Kozłowska, Justyna Agier

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Impact ofFrontiers in gastroenterology (Lausanne, Switzerland) · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Leptin ElicitsFrontiers in endocrinology · 2020
    Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Paulina ŻelechowskaDepartment of Experimental Immunology, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Ewa Brzezińska-BłaszczykDepartment of Experimental Immunology, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.ORCID 0000-0002-1466-4321
Magdalena WiktorskaDepartment of Molecular Cell Mechanisms, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Sylwia RóżalskaDepartment of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Sebastian WawrockiDepartment of Immunology and Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Elżbieta KozłowskaDepartment of Experimental Immunology, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Justyna AgierDepartment of Experimental Immunology, Faculty of Health Sciences, Medical University of Lodz, Lodz, Poland.
Medical University of Lodz · PLUniversity of Łódź · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A growing body of data indicates that adipocytokines, including leptin and adiponectin, are critical components not only of metabolic regulation but also of the immune system, mainly by influencing the activity of cells participating in immunological and inflammatory processes. As mast cells (MCs) are the key players in the course of those mechanisms, this study aimed to evaluate the impact of leptin and adiponectin on some aspects of MC activity. We documented that in vivo differentiated mature tissue MCs from the rat peritoneal cavity express a receptor for leptin (OB-R), as well as receptors for adiponectin (AdipoR1 and AdipoR2). We established that leptin, but not adiponectin, stimulates MCs to release of histamine as well as to generation of cysteinyl leukotrienes (cysLTs) and chemokine CCL2. We also found that both adipocytokines affect mRNA expression of various cytokines/chemokines. Leptin and adiponectin also activate MCs to produce reactive oxygen species. Moreover, we documented that leptin significantly augments the surface expression of receptors for cysLTs, i.e. CYSLTR1, CYSLTR2, and GPR17 on MCs, while adiponectin increases only GPR17 expression, and decreases CYSLTR2. Finally, we showed that both adipocytokines serve as potent chemoattractants for MCs. In intracellular signaling in MCs activated by leptin Janus-activated kinase 2, phospholipase C, phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase (ERK1/2), and p38 molecules play a part whereas the adiponectin-induced activity of MCs is mediated through PI3K, p38, and ERK1/2 pathways. Our observations that leptin and adiponectin regulate MC activity might indicate that adipocytokines modulate the different processes in which MCs are involved.

Indexed as

AdiponectinAnimalsCells, CulturedChemotaxisCysteineCytokinesFemaleHistamine ReleaseLeptinLeukotrienesMast CellsRats, WistarReactive Oxygen SpeciesReceptors, AdiponectinReceptors, LeukotrieneSignal TransductionAdiponectinadiponectin receptor 1, ratadiponectin receptor 2, ratAdipoq protein, ratCysteinecysteinyl-leukotrieneCytokinesLeptinLeukotrienesReactive Oxygen SpeciesReceptors, AdiponectinReceptors, Leukotrienehumoral factorsimmune responseinflammationmast cell

Identifiers

PMID31220342
PMCPMC6700464
OpenAlexW2951418629

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.